Information Journal Paper
APA:
Copy. (2017). SAT0226 A first-in-human, study of BMS-986165, a se-lective, potent, allosteric small molecule inhibitor of ty-rosine kinase 2. ANNALS OF THE RHEUMATIC DISEASES, 76(Suppl. 2), 0-0. SID. https://sid.ir/paper/720764/en
Vancouver:
Copy. SAT0226 A first-in-human, study of BMS-986165, a se-lective, potent, allosteric small molecule inhibitor of ty-rosine kinase 2. ANNALS OF THE RHEUMATIC DISEASES[Internet]. 2017;76(Suppl. 2):0-0. Available from: https://sid.ir/paper/720764/en
IEEE:
Copy, “SAT0226 A first-in-human, study of BMS-986165, a se-lective, potent, allosteric small molecule inhibitor of ty-rosine kinase 2,” ANNALS OF THE RHEUMATIC DISEASES, vol. 76, no. Suppl. 2, pp. 0–0, 2017, [Online]. Available: https://sid.ir/paper/720764/en